Overview:

Summary

GlobalData's clinical trial report, “Interstitial Cystitis Global Clinical Trials Review, Q1, 2011"" provides data on the Interstitial Cystitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Interstitial Cystitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Interstitial Cystitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Interstitial Cystitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Unaccomplished Trials of Interstitial Cystitis 18
Subjects Recruited Over a Period of Time 20
Prominent Sponsors 21
Top Companies Participating in Interstitial Cystitis Therapeutics Clinical Trials 23
Prominent Drug Comparison 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Pfizer Inc. 26
Clinical Trial Overview of Pfizer Inc. 26
Johnson & Johnson 27
Clinical Trial Overview of Johnson & Johnson 27
Watson Pharmaceuticals, Inc. 28
Clinical Trial Overview of Watson Pharmaceuticals, Inc. 28
Urigen Pharmaceuticals, Inc. 29
Clinical Trial Overview of Urigen Pharmaceuticals, Inc. 29
Mundipharma Research GmbH & Co. KG 30
Clinical Trial Overview of Mundipharma Research GmbH & Co. KG 30
Biomedical Development Corporation 31
Clinical Trial Overview of Biomedical Development Corporation 31
ICOS Corporation 32
Clinical Trial Overview of ICOS Corporation 32
TARIS BioMedical, Inc. 33
Clinical Trial Overview of TARIS BioMedical, Inc. 33
Capital District Health Authority, Canada 34
Clinical Trial Overview of Capital District Health Authority, Canada 34
MediciNova, Inc. 35
Clinical Trial Overview of MediciNova, Inc. 35
Allergan, Inc. 36
Clinical Trial Overview of Allergan, Inc. 36
Clinical Trial Overview of Top Universities / Institutes / Hospitals 37
William Beaumont Hospitals 37
Clinical Trial Overview of William Beaumont Hospitals 37
The National Institute of Diabetes and Digestive and Kidney Diseases 38
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 38
Assaf-Harofeh Medical Center 39
Clinical Trial Overview of Assaf-Harofeh Medical Center 39
Copenhagen University Hospital at Herlev 40
Clinical Trial Overview of Copenhagen University Hospital at Herlev 40
University of Alabama at Birmingham 41
Clinical Trial Overview of University of Alabama at Birmingham 41
Pelvic & Sexual Health Institute 42
Clinical Trial Overview of Pelvic & Sexual Health Institute 42
Scripps Health 43
Clinical Trial Overview of Scripps Health 43
The University of Texas M. D. Anderson Cancer Center 44
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 44
Children's Hospital Boston 45
Clinical Trial Overview of Children's Hospital Boston 45
IRCCS Policlinico S. Donato 46
Clinical Trial Overview of IRCCS Policlinico S. Donato 46
The University of Tokyo 47
Clinical Trial Overview of The University of Tokyo 47
Kaunas University of Medicine 48
Clinical Trial Overview of Kaunas University of Medicine 48
Georgetown University 49
Clinical Trial Overview of Georgetown University 49
CAMC Health System 50
Clinical Trial Overview of CAMC Health System 50
University of Washington 51
Clinical Trial Overview of University of Washington 51
University Hospital Inselspital, Berne 52
Clinical Trial Overview of University Hospital Inselspital, Berne 52
Queen's University 53
Clinical Trial Overview of Queen's University 53
University of Pennsylvania 54
Clinical Trial Overview of University of Pennsylvania 54
Beth Israel Deaconess Medical Center 55
Clinical Trial Overview of Beth Israel Deaconess Medical Center 55
Drexel University 56
Clinical Trial Overview of Drexel University 56
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 59
Secondary Research 59
About GlobalData 60
Contact Us 60
Disclaimer 60
Source 60"

List of Tables
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Interstitial Cystitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 11
Interstitial Cystitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Interstitial Cystitis Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Interstitial Cystitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Phase, 2011* 15
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 16
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Interstitial Cystitis Therapeutics Market, Global, Suspended Clinical Trials, 2011* 18
Interstitial Cystitis Therapeutics Market, Global, Terminated Clinical Trials, 2011* 19
Interstitial Cystitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Interstitial Cystitis Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Interstitial Cystitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 24
Interstitial Cystitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 25
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 26
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2011* 27
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Watson Pharmaceuticals, Inc., 2011* 28
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Urigen Pharmaceuticals, Inc., 2011* 29
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma Research GmbH & Co. KG, 2011* 30
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Biomedical Development Corporation, 2011* 31
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by ICOS Corporation, 2011* 32
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by TARIS BioMedical, Inc., 2011* 33
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Capital District Health Authority, Canada, 2011* 34
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by MediciNova, Inc., 2011* 35
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011* 36
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by William Beaumont Hospitals, 2011* 37
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2011* 38
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Assaf-Harofeh Medical Center, 2011* 39
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Copenhagen University Hospital at Herlev, 2011* 40
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2011* 41
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Pelvic & Sexual Health Institute, 2011* 42
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Scripps Health, 2011* 43
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2011* 44
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Hospital Boston, 2011* 45
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by IRCCS Policlinico S. Donato, 2011* 46
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2011* 47
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaunas University of Medicine, 2011* 48
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Georgetown University, 2011* 49
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by CAMC Health System, 2011* 50
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2011* 51
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2011* 52
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Queen's University, 2011* 53
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2011* 54
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2011* 55
Interstitial Cystitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Drexel University, 2011* 56"

List of Figures
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Interstitial Cystitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Interstitial Cystitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Interstitial Cystitis Therapeutics Clinical Trials, North America, Top Countries (%), 2011* 13
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 15
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 16
Interstitial Cystitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 17
Interstitial Cystitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 20
Interstitial Cystitis Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 21
Interstitial Cystitis  Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 23
Interstitial Cystitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 25
GlobalData Methodology 59